Andrew Hykes - Mar 12, 2023 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Mar 12, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 07:08 PM
Previous filing
Feb 22, 2023
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $0 +431K +329.66% $0.00 561K Mar 12, 2023 Direct
holding NARI Common Stock 1.55K Mar 12, 2023 By Child 1
holding NARI Common Stock 1.55K Mar 12, 2023 By Child 2
holding NARI Common Stock 1.55K Mar 12, 2023 By Child 3
holding NARI Common Stock 1K Mar 12, 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Restricted Stock Unit Options Exercise $0 -431K -100% $0.00* 0 Mar 12, 2023 Common Stock 431K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.